WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

A COMPREHENSIVE REVIEW ON KERENDIA (FINERENONE)

Bulbule Laxman D.*, Thakre Shital B., Shingne Snehal S., Prof. Hemlata Bhawar, Dr. Sanjay Bhawar

.

Abstract

Finerenone is a third-generation nonsteroidal mineralocorticoid receptor antagonist with higher mineralocorticoid receptor (MR) binding potential. Steroidal mineralocorticoid receptor antagonists, when added to a RAS blocker, they helps to reduce proteinuria in patients with chronic kidney disease but may be underused because of a high risk of adverse effect. Finerenone is used to treat chronic heart failure (CHF) with reduced ejection fraction (HFrEF). However, this is the review compiling the medical uses and chemistry of Finerenone.

Keywords: Kerendia, Mineralocorticoid Receptor, Antagonist, Steroids, Hormone, Diuretics.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More